Resultados de la búsqueda 161-170 de 3047 para anti-TNF drugs

  1. Síndrome de Stevens-Johnson - Diagnóstico y tratamiento - Mayo Clinic

    AskMayoExpert. Drug eruption. Mayo Clinic; 2019. AskMayoExpert. Nonimmunoglobulin e-mediated (non-IgE) drug sensitivity. Mayo Clinic; 2019. High WA. Stevens- ...

  2. Enfermedad de Alzheimer: los medicamentos ayudan a controlar los síntomas - Mayo Clinic

    Medications for memory, cognition and dementia-related behaviors. ... Impact of Anti-amyloid-β Monoclonal Antibodies on ... Alzheimers Medicines help manage ...

  3. L-arginina - Mayo Clinic

    Natural Medicines. https://naturalmedicines.therapeuticresearch.com. Accessed Dec. 20, 2020. L-arginine. Facts & Comparisons eAnswers. https://www ...

  4. Neurología - Noticias de Mayo Clinic

    junio 2024. Clot-busting medication helps retiree return to the open road after a stroke June 28, 2024, 04:00 p.m. CDT.

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...

  6. Vitamina E - Mayo Clinic

    Vitamin E. Micromedex 2.0 Healthcare Series. http://www.micromedexsolutions.com. Accessed Aug. 10, 2017. Vitamin E. Natural Medicines. https://naturalmedicines.

  7. Cirugía - Ensayos clínicos - Mayo Clinic

    Drugs used in chemotherapy, such as cisplatin, doxorubicin, fluorouracil, vincristine sulfate, carboplatin, etoposide, irinotecan, sorafenib, gemcitabine ...

  8. Enfermedades infecciosas - Ensayos clínicos - Mayo Clinic

    ... treatment variations, as well as the factors that ... The third aim is to measure SARS-CoV-2 anti-spike and anti ... treatment variations, as well as the ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to test drug enfortumab vedotin in participants with a type of bladder cancer called non-muscle invasive bladder cancer (NMIBC) ...

  10. Dermatología - Ensayos clínicos - Mayo Clinic

    The study will enroll advanced cancer patients with unresectable or metastatic disease who are refractory to or are not candidates for standard approved therapy ...